Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.
Aveanna Healthcare Holdings Inc. reports developments for a home-based healthcare platform serving pediatric and adult patient populations across 38 states. Company updates commonly cover nursing, rehabilitation services, school-based occupational nursing, therapy services, day treatment centers, home health and hospice, enteral nutrition products, case management, and respite care for medically fragile and chronically ill patients.
Recurring AVAH news includes earnings releases, financial guidance, investor presentations and conference participation, as well as clinical quality initiatives such as Heartways program certification. Updates also address community-service programs and operating themes tied to care coordination among payers, physicians, hospitals, and other healthcare providers.
Aveanna Healthcare (NASDAQ: AVAH) reported Q1 2026 revenue of $647.9 million, up 15.9% year over year, with net income of $41.7 million versus $5.2 million and diluted EPS of $0.19.
Adjusted EBITDA rose 25.2% to $84.4 million, and full-year 2026 revenue and Adjusted EBITDA guidance were both raised.
Aveanna (NASDAQ: AVAH) announced that its management team will participate in the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026. Management will present at 2:40 p.m. CST and host same-day 1x1 investor meetings, with a live webcast and limited-time replay via the company’s investor relations website.
Aveanna Healthcare (NASDAQ: AVAH) said its management team will attend the Barclays 30th Annual Leveraged Finance Conference in Austin, TX on May 19, 2026.
Management will host one-on-one investor meetings that day; no public presentation or financial update was announced.
Aveanna (NASDAQ: AVAH) will release Q1 2026 results before market open on May 14, 2026 and hold a conference call at 10:00 a.m. ET the same day.
Live dial-in, international numbers, and a webcast are provided; a replay (passcode 13759633) will be available through May 21, 2026.
Aveanna Healthcare (NASDAQ: AVAH) launched its second annual Aveanna Cares Month of Service in April 2026, expanding participation and partnerships with a goal of delivering 7,500 volunteer hours nationwide. The program mobilizes teams across all 38 states the company serves to support children, seniors, and medically fragile populations.
In its inaugural year the program generated more than 5,000 volunteer hours and nearly 100 events; year two emphasizes deeper local partnerships and year-round volunteer opportunities.
Aveanna Healthcare (NASDAQ: AVAH) reported strong fourth-quarter and full-year 2025 results with meaningful revenue, profitability, and cash‑flow gains.
Q4 revenue was $662.5M (+27.4%), Q4 net income $178.8M, Q4 Adjusted EBITDA $85.0M (+54%). FY revenue was $2,433.2M (+20.2%) and FY Adjusted EBITDA $320.9M (+74.8%).
Company maintained 2026 guidance of $2.54–$2.56B revenue and $318–$322M Adjusted EBITDA, announced a $175.5M Family First Homecare acquisition expected to close in Q2 2026, and reported $131.0M free cash flow and $1,486.7M total indebtedness.
Aveanna Healthcare (NASDAQ: AVAH) agreed to acquire Family First Homecare, a pediatric private duty nursing provider with 27 locations in seven states. Aveanna plans to fund the deal with cash on hand and existing short-term credit borrowing. Closing is expected in Q2 2026, subject to customary conditions.
The acquisition expands Aveanna’s specialized pediatric footprint across Florida, Illinois, Iowa, Pennsylvania, South Dakota, Texas and North Carolina and follows Family First’s 2021 minority investment from Trivest Partners.
Aveanna (NASDAQ: AVAH) will release fourth quarter and full year 2025 results before market open on Thursday, March 19, 2026, followed by a conference call at 10:00 a.m. ET.
Investors can join by phone or webcast; a replay with passcode 13757396 will be available three hours after the call through March 26, 2026, and an online replay will remain for one week.
Aveanna Healthcare (NASDAQ: AVAH) announced that Aveanna Home Health and Hospice earned CHAP Disease Program Certification for Heart Failure on Feb 11, 2026. CHAP certification recognizes program structure, clinician education, quality metrics, and patient self-management tools under nationally recognized standards.
The certified Heartways program provides evidence-based care pathways for home health and hospice patients, aiming to reduce hospitalizations, improve symptom management, and strengthen patient and caregiver education.
Aveanna Healthcare (NASDAQ: AVAH) updated full-year guidance for fiscal 2025 and provided initial fiscal 2026 guidance on April 4, 2026. FY2025 revenue is now expected at $2.425–$2.445 billion with net income of $181–$220 million and Adjusted EBITDA of $318–$322 million. FY2026 revenue guidance is $2.54–$2.56 billion with Adjusted EBITDA of $318–$322 million. Results are preliminary, unaudited, and subject to change upon completion of year-end close and audit.